Target intelligence / Profile preview

Ribosomal DNA G-quadruplex (rDNA G4)

Target
rDNA G4
Molecular classification
Other
01

Overview

Ribosomal DNA G-quadruplexes (rDNA G4s) are non-canonical secondary structures formed within the guanine-rich sequences of the ribosomal DNA repeats located in the nucleolus. These structures play a pivotal role in regulating ribosomal RNA (rRNA) transcription by modulating the activity of RNA polymerase I (Pol I) and the binding of nucleolar proteins like nucleolin (Nucleic Acids Research, 2019). In many cancers, ribosome biogenesis is hyperactivated to meet the high protein synthesis demands of rapidly dividing cells, making rDNA G4s an attractive therapeutic target (Nature Reviews Cancer, 2018). Small molecule stabilizers, such as CX-5461 and Quarfloxin, bind to these G4 structures to disrupt Pol I transcription, thereby inducing nucleolar stress and activating DNA damage response pathways (Cancer Discovery, 2017). This targeted disruption leads to cell cycle arrest and apoptosis, particularly in cancer cells that are "addicted" to high levels of ribosome production (Nature Chemical Biology, 2008). Consequently, rDNA G4s represent a strategic vulnerability in oncology, providing a mechanism to selectively inhibit the fundamental process of protein synthesis in malignant tissues (Trends in Pharmacological Sciences, 2020).

Other names
rDNA G-quadruplexNucleolar G-quadruplexRibosomal DNA G4rDNA G-quadruplex DNA
02

Mechanism of action

Stabilization of G-quadruplex structures within the ribosomal DNA template, which physically blocks the progression of RNA polymerase I, leading to the inhibition of ribosomal RNA synthesis and the induction of nucleolar stress-mediated apoptosis.

03

Biological functions

Cell proliferationOther
04

Disease associations

Cancer
05

Safety considerations

Potential for systemic DNA damageHematologic toxicitiesOff-target effects on non-nucleolar G-quadruplexes
06

Interacting drugs

CX-5461 (Pidnarulex)

1 more in the full profile.

07

Biomarkers

45S pre-rRNA levelsNucleophosmin (NPM1) translocationp53 expressionγH2AX

Beyond the preview

Go deeper on Ribosomal DNA G-quadruplex (rDNA G4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal DNA G-quadruplex (rDNA G4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call